The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies

Epilepsy is one of the most common neurological chronic disorders, with an estimated prevalence of 0. 5 – 1%. Currently, treatment options for epilepsy are predominantly based on the administration of symptomatic therapy. Most patients are able to achieve seizure freedom by the first two appropriate...

Descripción completa

Detalles Bibliográficos
Autores principales: Fattorusso, Antonella, Matricardi, Sara, Mencaroni, Elisabetta, Dell'Isola, Giovanni Battista, Di Cara, Giuseppe, Striano, Pasquale, Verrotti, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258148/
https://www.ncbi.nlm.nih.gov/pubmed/34239494
http://dx.doi.org/10.3389/fneur.2021.674483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258148/
https://www.ncbi.nlm.nih.gov/pubmed/34239494
http://dx.doi.org/10.3389/fneur.2021.674483

Ejemplares similares